What is the Shalby PE ratio today?
Shalby's PE ratio is 33.4 at the 29 October 2026 close (₹121.96 a share): a market capitalisation of ₹1,311 crore divided by consolidated net profit of ₹39.3 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹37.4 crore) it is 35.1.
What is the Shalby net worth?
Shalby's net worth — shareholders' equity in its consolidated balance sheet — was ₹1,005 crore on 31 March 2026, up 1.3% from ₹992 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹1,311 crore at the 29 October 2026 close.
What is the Shalby book value per share?
Shalby's book value per share was ₹93.49 on 31 March 2026: shareholders' equity of ₹1,005 crore divided by the 10.75 crore shares in issue, up 1.3% from ₹92.31 a year earlier. The share price at the 29 October 2026 close was ₹121.96.
What is the Shalby PB ratio (price to book value)?
Shalby's price-to-book (PB) ratio is 1.30 at the 29 October 2026 close: a market capitalisation of ₹1,311 crore divided by shareholders' equity (book value) of ₹1,005 crore on 31 March 2026. That is a book value of ₹93.49 per share against a share price of ₹121.96.
What is the Shalby ROE and ROCE?
In FY26, Shalby's return on equity (ROE) was 3.7% and its return on capital employed (ROCE) was 5.8%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 0.6% and ROCE 5.3%.
What is the Shalby shareholding pattern?
On 30 September 2026, Shalby's shares were held by promoters 74.33%, foreign portfolio investors (FII/FPI) 4.65%, domestic institutions (DII) 0.31% (including mutual funds at 0.02%) and retail and other non-institutional investors 20.08%. Over the year, FII holding was up 0.01 percentage points from 4.64% and DII holding was up 0.11 percentage points from 0.20%.
What is the Shalby market cap?
Shalby's market capitalisation was ₹1,311 crore at the 29 October 2026 close: 10.75 crore shares at ₹121.96 each.
What is the Shalby EPS?
Shalby's basic earnings per share (EPS) were ₹3.23 in FY26. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹3.50.
When are the Shalby next results?
Shalby will announce its Q2 FY27 results (July–September 2026) on Tuesday, 3 November 2026, the date of the board meeting it has notified to the exchanges.
Is Shalby debt free?
No. Shalby had borrowings of ₹540 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.54. Its cash and current investments were ₹84.2 crore, so its net debt was ₹455 crore.
What is the Shalby debt to equity ratio?
Shalby's debt-to-equity ratio was 0.54 on 31 March 2026: borrowings of ₹540 crore against total equity of ₹1,006 crore. A year earlier, on 31 March 2025, it was 0.43.
What is the Shalby promoter holding?
Promoters held 74.33% of Shalby on 30 September 2026, unchanged from both the previous quarter and a year earlier, according to the shareholding pattern filed with NSE.
What is the Shalby free cash flow?
In FY26, Shalby generated ₹0.8 lakh of cash from operations and spent ₹149 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of −₹149 crore. In FY25 it was −₹75.8 crore.
What are the Shalby latest quarterly results?
Shalby's latest results are for Q1 FY27 (April–June 2026), filed on 12 August 2026: consolidated net profit ₹10.8 crore, up 21.6% from ₹8.9 crore in Q1 FY26; revenue from operations ₹331 crore, up 11.7% year on year.
What is the Shalby revenue and profit in FY26?
In FY26 (April 2025–March 2026), Shalby's consolidated net profit was ₹37.4 crore, up 500.9% from ₹6.2 crore in FY25, on revenue from operations of ₹1,141 crore (up 5.0%). Over three years, from FY23, net profit was down 44.8%.
How does Shalby compare with its peers?
On FY26 consolidated figures, against Gujarat Kidney And Super Speciality, GPT Healthcare and Indraprastha Medical Corporation: Shalby's operating margin of 6.4% is the lowest of the four (Gujarat Kidney And Super Speciality 27.1%, GPT Healthcare 12.1%, Indraprastha Medical Corporation 15.1%; peer average 18.1%); its return on equity of 3.7% is the lowest of the four (Gujarat Kidney And Super Speciality 6.1%, GPT Healthcare 16.3%, Indraprastha Medical Corporation 27.5%; peer average 16.6%).
How does the Shalby PE ratio compare with its peers?
At the 29 October 2026 closing prices, on FY26 net profit, Shalby's PE ratio is 35.1, the second highest of the four: Gujarat Kidney And Super Speciality 87.4, GPT Healthcare 26.6 and Indraprastha Medical Corporation 15.9, a peer average of 43.3. Each is the company's market capitalisation at that price divided by its FY26 net profit.
Shalby vs Gujarat Kidney And Super Speciality: how do they compare?
In FY26, Shalby earned net profit of ₹37.4 crore on revenue of ₹1,141 crore, against ₹15.5 crore on ₹82 crore for Gujarat Kidney And Super Speciality. Shalby's operating margin was 6.4% (Gujarat Kidney And Super Speciality 27.1%) and its return on equity 3.7% (Gujarat Kidney And Super Speciality 6.1%). At the 29 October 2026 close, Shalby's market capitalisation was ₹1,311 crore against ₹1,355 crore for Gujarat Kidney And Super Speciality, and its PE ratio on FY26 profit 35.1 against 87.4.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.
